TwinStrand Biosciences: Michael Pellini

May 06, 2021

Michael Pellini has joined the board of directors of TwinStrand Biosciences in connection with the firm's recent Series B financing round. He is a partner at investment firm Section 32, the former CEO and chairman of Foundation Medicine, and the former president and chief operating officer of Clarient.